Molecular transport during fibrin clot lysis
- 1 March 2000
- journal article
- Published by Elsevier in Fibrinolysis and Proteolysis
- Vol. 14 (2-3) , 98-113
- https://doi.org/10.1054/fipr.2000.0072
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- The current role of thrombolytic therapy in the treatment of acute myocardial infarctionFibrinolysis and Proteolysis, 1999
- Thrombolytic agents — an updated overviewFibrinolysis and Proteolysis, 1998
- The urokinase receptorFibrinolysis and Proteolysis, 1998
- The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieuBlood Coagulation & Fibrinolysis, 1998
- Progress in clinical fibrinolysisFibrinolysis and Proteolysis, 1997
- Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.Proceedings of the National Academy of Sciences, 1996
- The physiological aspects of fibrinolysisThrombosis Research, 1994
- Physiological consequences of loss of plasminogen activator gene function in miceNature, 1994
- Spontaneous clot lysis in whole human plasma by endogenous tissue type and urokinase type plasminogen activators: Demonstration of a promoting effect by t-PA and by platelets on urokinaseFibrinolysis, 1988
- Relationship between tissue plasminogen activator and the activators in blood and vascular wallThrombosis Research, 1980